Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression

被引:84
作者
Yamagishi, S
Takeuchi, M
Matsui, T
Nakamura, K
Imaizumi, T
Inoue, H
机构
[1] Kurume Univ, Sch Med, Dept Internal Med 3, Kurume, Fukuoka 8300011, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Kanazawa, Ishikawa 9201181, Japan
[3] Kurume Univ, Sch Med, Radioisotope Inst Basic & Clin Med, Kurume, Fukuoka 8300011, Japan
关键词
advanced glycation end products; angiotensin II; diabetic retinopathy; oxidative stress; pericyte loss; receptor for AGEs;
D O I
10.1016/j.febslet.2005.06.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Advanced glycation end product (AGE)-their receptor (RAGE) and angiotensin II (AII) are implicated in diabetic retinopathy. However, a crosstalk between the two is not fully understood. In vivo, AGE injection stimulated RAGE expression in the eye of spontaneously hypertensive rats, which was blocked by an AII-type 1 receptor blocker, telmisartan. In vitro, AII-type 1 receptor-mediated reactive oxygen species generation elicited RAGE gene expression in pericytes through NF-kappa B activation. Further, AII augmented AGE-induced pericyte apoptosis, the earliest hallmark of diabetic retinopathy. Our present study may implicate a crosstalk between AGE-RAGE system and AII in diabetic retinopathy. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4265 / 4270
页数:6
相关论文
共 41 条
[1]
Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes [J].
Amano, S ;
Yamagishi, S ;
Inagaki, Y ;
Nakamura, K ;
Takeuchi, M ;
Inoue, H ;
Imaizumi, T .
MICROVASCULAR RESEARCH, 2005, 69 (1-2) :45-55
[2]
Anderson S, 1997, KIDNEY INT, pS107
[3]
AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES [J].
ANTONELLIORLIDGE, A ;
SAUNDERS, KB ;
SMITH, SR ;
DAMORE, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4544-4548
[4]
[5]
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept [J].
Bierhaus, A ;
Hofmann, MA ;
Ziegler, R ;
Nawroth, PP .
CARDIOVASCULAR RESEARCH, 1998, 37 (03) :586-600
[6]
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[7]
Angiotensin receptors in cardiac and renal hypertrophy in rats [J].
Brown, L ;
Passmore, M ;
Duce, B ;
Sernia, C .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) :2925-2929
[8]
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].
Chaturvedi, N ;
Sjolie, AK ;
Stephenson, JM ;
Abrahamian, H ;
Keipes, M ;
Castellarin, A ;
Rogulja-Pepeonik, Z ;
Fuller, JH .
LANCET, 1998, 351 (9095) :28-31
[9]
RETINAL VASCULAR PATTERNS .4. DIABETIC RETINOPATHY [J].
COGAN, DG ;
KUWABARA, T ;
TOUSSAINT, D .
ARCHIVES OF OPHTHALMOLOGY, 1961, 66 (03) :366-&
[10]
The role of the renin-angiotensin-aidosterone system in diabetes and its vascular complications [J].
Cooper, ME .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (11) :16S-20S